Stevanato Group price target lowered to $17.50 from $23 at Jefferies

Jefferies lowered the firm’s price target on Stevanato Group (STVN) to $17.50 from $23 and keeps a Hold rating on the shares. Injectable packaging Contract Manufacturing Organizations face headwinds from vaccines and shifts to oral and multi-dose GLP-1 formats, though the firm thinks oral GLP-1 risk is “largely priced in,” the analyst tells investors.